Aetna Inc. (NYSE:AET) is struggling to gain traction with investors, as evidenced by its 3.6 million shares volume. The daily trading volume average remained 3.32 million shares over the course of 3 months. The stock had opened the regular trading at $183.43 and managed a 0.4% price change to reach $184.21 through the close.Aetna Inc. (AET) Analyst Opinion
Aetna Inc. has a consensus outperform rating from 19 Wall Street analysts, and the number of shares currently sold short amount to at least 0.84% of shares outstanding. The stock spiked 1.45% last month and is up 2.12 this year. Wall Street is only getting more bullish on the stock, with 8 of analysts who cover AET having a buy-equivalent rating. Analysts have placed a $195.12 price target on Aetna Inc., suggesting a 5.92% gain from recent close. It’s currently trading about -4.24% below its 52-week high.Aetna Inc. Earnings Surprise
Aetna Inc. (AET) surprised the stock market in its last reported earnings when it earned $2.45 a piece versus the consensus-estimated $2.08. Its revenue totaled $15.16 billion down -2.16% from the previous quarter.Aetna Inc. (NYSE:AET) Intraday View
This stock (AET) is ahead of its 52-week low with 58.75%. Its last month’s stock price volatility remained 1.16% which for the week stands at 1.14%. The share price has moved forward from its 20 days moving average, trading at a distance of 1.74% and stays 3.44% away from its 50 days moving average. Over the last five days, shares have managed 0.46% gains and now is up 17.47% since hitting its 200-day moving average of $164.55. Aetna Inc. (AET) has made its way to a 12-month gain of 50.22%.
Turning to Exact Sciences Corporation (NASDAQ:EXAS), its shares were trading at $55.06 a gain of $1.1, on the trading floor. The stock, after opening at $54.01, touched a high of $55.4293 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Exact Sciences Corporation has 6 buy ratings, 5 holds and 0 sells even after the stock tumbled -13.43% from its high of $63.60 to a $6.56 billion market value through last close.Exact Sciences Corporation (EXAS) Consensus Price Target
The company’s consensus rating on Reuter’s scale remained unchanged from 1.92 to 1.92 during a month. Analysts set a 12-month price target of $59.1 a share. The target implies a 7.34% spike from where the shares are currently trading. Also, the current price highlights a discount of 21.69% to analysts’ high consensus price target.Exact Sciences Corporation (NASDAQ:EXAS) Intraday Trading
The counter witnessed a trading volume of 1.68 million shares versus an average volume of 1.82 million shares during last trading session. Its last month’s stock price volatility remained 6.86% which for the week approaches 4.57%. The lowest price the stock reached in the last trading day was $53.02 and compares with the $16.95 52-week low. The stock recovered 224.84% since its low point and has performed 4.8% year-to-date.